Structured Cardiac Assessment and Treatment Following Exacerbations of COPD (SCATECOPD): A Pilot Randomised Controlled Trial
<b>Background/Objectives</b>: Heart disease is common in COPD, yet it is underdiagnosed and undertreated. Heart failure (HF) is undiagnosed in up to 20% of hospital inpatients. Hospitalised exacerbations of COPD (ECOPD) confer high mortality and readmission rates, with an elevated tempor...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | Joseph Kibbler, Eduwin Pakpahan, Stephen McCarthy, Rebecca Webb-Mitchell, Arun Prasad, David P. Ripley, Joanne Gray, Stephen C. Bourke, John Steer |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/3/658 |
Similar Items
A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
by: Wilhelm Bertrams, et al.
Published: (2024-03-01)
by: Wilhelm Bertrams, et al.
Published: (2024-03-01)
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort
by: N. Frantzi, et al.
Published: (2024-05-01)
by: N. Frantzi, et al.
Published: (2024-05-01)
The Increased Burden of Morbidity Over the Life-Course Among Patients with COPD: A Register-Based Cohort Study in Sweden
by: Smith C, et al.
Published: (2024-06-01)
by: Smith C, et al.
Published: (2024-06-01)
One-year mortality after severe COPD exacerbation in Bulgaria
by: Evgeni Mekov, et al.
Published: (2016-12-01)
by: Evgeni Mekov, et al.
Published: (2016-12-01)
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)
Insufficient Pulmonary Rehabilitation Uptake After Severe Exacerbation of COPD: A Multicentre Study in the South West Region of France
by: Gueçamburu M, et al.
Published: (2024-07-01)
by: Gueçamburu M, et al.
Published: (2024-07-01)
Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care
by: Michael Lawless, et al.
Published: (2022-01-01)
by: Michael Lawless, et al.
Published: (2022-01-01)
Prevalence of concealed and overt chronic renal failure in patients with COPD
by: Abdelsadek H. Al-Aarag, et al.
Published: (2017-01-01)
by: Abdelsadek H. Al-Aarag, et al.
Published: (2017-01-01)
Коморбидность в клинической практике. Часть 1
by: А. Л. Вёрткин, et al.
Published: (2011-02-01)
by: А. Л. Вёрткин, et al.
Published: (2011-02-01)
Characterisation of morbidity in a COPD hospital cohort
by: A. Duarte-de-Araújo, et al.
Published: (2019-07-01)
by: A. Duarte-de-Araújo, et al.
Published: (2019-07-01)
Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01)
by: W MaxNee
Published: (2003-05-01)
Longitudinal anemia status and risk for adverse outcomes in former smokers with COPD
by: Yukiko Kunitomo, et al.
Published: (2024-12-01)
by: Yukiko Kunitomo, et al.
Published: (2024-12-01)
Systematic review and meta-analysis of prevalence of undiagnosed major cardiac comorbidities in COPD
by: Joseph Kibbler, et al.
Published: (2023-11-01)
by: Joseph Kibbler, et al.
Published: (2023-11-01)
Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)
Validation of Clinical COPD Phenotypes for Prognosis of Long-Term Mortality in Swedish and Dutch Cohorts
by: S. Gagatek, et al.
Published: (2022-12-01)
by: S. Gagatek, et al.
Published: (2022-12-01)
Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis
by: Hala Alzaid, et al.
Published: (2021-07-01)
by: Hala Alzaid, et al.
Published: (2021-07-01)
Renaming COPD exacerbations: the UK respiratory nursing perspective
by: Christine Mwasuku, et al.
Published: (2021-09-01)
by: Christine Mwasuku, et al.
Published: (2021-09-01)
COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01)
by: K. Yu. Gashynova
Published: (2015-03-01)
COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)
by: Gashynova K.Yu.
Published: (2015-03-01)
Identification and assessment of COPD exacerbations
by: A.S. Oliveira, et al.
Published: (2018-01-01)
by: A.S. Oliveira, et al.
Published: (2018-01-01)
What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study
by: Karrasch S, et al.
Published: (2016-08-01)
by: Karrasch S, et al.
Published: (2016-08-01)
Comparison of the predictive performance of Cumulative Illness Rating Scale, Charlson Comorbidity Index and COMCOLD Index for moderate-to-severe exacerbations in elderly subjects with chronic obstructive pulmonary disease
by: Edoardo Pirera, et al.
Published: (2025-12-01)
by: Edoardo Pirera, et al.
Published: (2025-12-01)
Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity
by: Sophia Eilat-Tsanani, et al.
Published: (2024-12-01)
by: Sophia Eilat-Tsanani, et al.
Published: (2024-12-01)
The problem of multimorbidity in a modern therapeutic clinic
by: E. V. Sevostyanova, et al.
Published: (2022-04-01)
by: E. V. Sevostyanova, et al.
Published: (2022-04-01)
Features of multimorbidity in elderly and senile people with hypertension
by: V. V. Popov, et al.
Published: (2021-05-01)
by: V. V. Popov, et al.
Published: (2021-05-01)
THE CONCEPT OF MULTIMORBIDITY IN RHEUMATOLOGIC PRACTICE
by: A. V. Gordeev, et al.
Published: (2014-09-01)
by: A. V. Gordeev, et al.
Published: (2014-09-01)
COPD and Comorbid Mental Health: Addressing Anxiety, and Depression, and Their Clinical Management
by: Rayan A. Siraj
Published: (2025-08-01)
by: Rayan A. Siraj
Published: (2025-08-01)
Interstitial lung abnormality in COPD is inversely associated with the comorbidity of lung cancer
by: Jianrui Zheng, et al.
Published: (2024-10-01)
by: Jianrui Zheng, et al.
Published: (2024-10-01)
COPD exacerbations: management and hospital discharge
by: A.J. Reis, et al.
Published: (2018-11-01)
by: A.J. Reis, et al.
Published: (2018-11-01)
Oxidant and antioxidant balance in stable COPD patients and during acute COPD exacerbations
by: Kubra Cansiz, et al.
Published: (2020-09-01)
by: Kubra Cansiz, et al.
Published: (2020-09-01)
Impact of anxiety and depression on the prognosis of copd exacerbations
by: Martínez-Gestoso Sandra, et al.
Published: (2022-04-01)
by: Martínez-Gestoso Sandra, et al.
Published: (2022-04-01)
The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
by: Wacker ME, et al.
Published: (2017-12-01)
by: Wacker ME, et al.
Published: (2017-12-01)
Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review
by: Paul Jones, et al.
Published: (2024-12-01)
by: Paul Jones, et al.
Published: (2024-12-01)
Expiratory central airway collapse in stable COPD and during exacerbations
by: Paul Leong, et al.
Published: (2017-08-01)
by: Paul Leong, et al.
Published: (2017-08-01)
Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)
Comorbid conditions as predictors of mortality in severe COPD – an eight-year follow-up cohort study
by: Gabriella Eliason, et al.
Published: (2023-01-01)
by: Gabriella Eliason, et al.
Published: (2023-01-01)
DIFFICULTY OF COPD PREDICTING AS A CHALLENGE TO MODERN CLINICAL PULMONOLOGY
by: M. A. Karnaushkina, et al.
Published: (2016-08-01)
by: M. A. Karnaushkina, et al.
Published: (2016-08-01)
Risk Factors for Development and Severity of COVID-19 in COPD Patients
by: Matteo Bonato, et al.
Published: (2021-08-01)
by: Matteo Bonato, et al.
Published: (2021-08-01)
Clinical factors and comorbidities affecting the cost of hospital-treated COPD
by: Deniz S, et al.
Published: (2016-12-01)
by: Deniz S, et al.
Published: (2016-12-01)
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease
by: Camiciottoli G, et al.
Published: (2016-09-01)
by: Camiciottoli G, et al.
Published: (2016-09-01)
Similar Items
-
A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
by: Wilhelm Bertrams, et al.
Published: (2024-03-01) -
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort
by: N. Frantzi, et al.
Published: (2024-05-01) -
The Increased Burden of Morbidity Over the Life-Course Among Patients with COPD: A Register-Based Cohort Study in Sweden
by: Smith C, et al.
Published: (2024-06-01) -
One-year mortality after severe COPD exacerbation in Bulgaria
by: Evgeni Mekov, et al.
Published: (2016-12-01) -
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)
